SEC Form 4 · accession 0000884731-16-000071
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jayne M. Gansler
Officer — Senior V.P. Human Resources
Period of report
Jun 6, 2016
Accepted (ET)
Jun 8, 2016 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $8.86 | Jun 6, 2016 | A | 144,000 | A | Jun 6, 2017 | Jun 6, 2026 | Common Stock | 144,000 | 144,000 | D |
| Restricted Stock UnitsF2 | $0.00 | Jun 6, 2016 | A | 72,000 | A | Jun 6, 2017 | Jun 6, 2026 | Common Stock | 72,000 | 72,000 | D |
Explanation of responses
- F1The options vest as to 25% of the award (36,000 shares) on May 31, 2017, and as to 6.25% of the award (9,000shares) every three months thereafter for 36 months.
- F2Vest as to 33 1/3% of the award (24,000) per year on each anniversary of grant.